Recombinant multi-species SNRPE protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SNRPE protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a core component of U small nuclear ribonucleoproteins, which are key components of the pre-mRNA processing spliceosome. The encoded protein plays a role in the 3' end processing of histone transcripts. This protein is one of the targets in the autoimmune disease systemic lupus erythematosus, and mutations in this gene have been associated with hypotrichosis. Several pseudogenes of this gene have been identified. [provided by RefSeq, Jun 2016]
The Alternative Names of target: HYPT11,SME,SNRNPE,SNRPE,Sm protein E (Sm-E,Sm-E,SmE),Small nuclear ribonucleoprotein E,Snrpe,sm-E,snRNP-E
Go
to SNRPE products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP11513-Ag-1/ GM-Tg-hg-IP11513-Ag-2 | Human SNRPE protein | Human |
| GM-Tg-rg-IP11513-Ag-1/ GM-Tg-rg-IP11513-Ag-2 | Rat SNRPE protein | Rat |
| GM-Tg-mg-IP11513-Ag-1/ GM-Tg-mg-IP11513-Ag-2 | Mouse SNRPE protein | Mouse |
| GM-Tg-cynog-IP11513-Ag-1/ GM-Tg-cynog-IP11513-Ag-2 | Cynomolgus/Rhesus macaque SNRPE protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP11513-Ag-1/ GM-Tg-felg-IP11513-Ag-2 | Feline SNRPE protein | Feline |
| GM-Tg-cang-IP11513-Ag-1/ GM-Tg-cang-IP11513-Ag-2 | Canine SNRPE protein | Canine |
| GM-Tg-bovg-IP11513-Ag-1/ GM-Tg-bovg-IP11513-Ag-2 | Bovine SNRPE protein | Bovine |
| GM-Tg-equg-IP11513-Ag-1/ GM-Tg-equg-IP11513-Ag-2 | Equine SNRPE protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP11513-Ag-1/ GM-Tg-hg-IP11513-Ag-2;
GM-Tg-rg-IP11513-Ag-1/ GM-Tg-rg-IP11513-Ag-2;
GM-Tg-mg-IP11513-Ag-1/ GM-Tg-mg-IP11513-Ag-2; GM-Tg-cynog-IP11513-Ag-1/ GM-Tg-cynog-IP11513-Ag-2; GM-Tg-felg-IP11513-Ag-1/ GM-Tg-felg-IP11513-Ag-2; GM-Tg-cang-IP11513-Ag-1/ GM-Tg-cang-IP11513-Ag-2; GM-Tg-bovg-IP11513-Ag-1/ GM-Tg-bovg-IP11513-Ag-2; GM-Tg-equg-IP11513-Ag-1/ GM-Tg-equg-IP11513-Ag-2 |
| Products Name | SNRPE protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | SNRPE |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SNRPE protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.